Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

F

FTH

Faeth Therapeutics Inc

27.34

Aug 03 • 3:59 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Small NASD

Peers: BCTX CLRB JSPR LGVN MRKR NXTC PLUR TPST TRAW VTGN

| Held by: VXF IWC

Scroll to Statements

Index	-
Market Cap	704.79M
Enterprise Value	831.52M
Income	-184.46M
Sales	0.00M
Book/sh	-102.43
Cash/sh	7.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Feb 04, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	3.48
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	14.39
Current Ratio	14.39
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-142.73
EPS next Y	-6.10
EPS next Q	-2.82
EPS this Y	-208.68%
EPS next Y	88.17%
EPS next 5Y	29.55%
EPS past 3/5Y	19.15% -4.83%
Sales past 3/5Y	- -
EPS Y/Y TTM	-518.34%
Sales Y/Y TTM	-
EPS Q/Q	-2312.30%
Sales Q/Q	-
Earnings	May 15 BMO
EPS/Sales Surpr.	-21101.61% -

Insider Own	17.77%
Insider Trans	0.51%
Inst Own	13.18%
Inst Trans	11.50%
ROA	-151.41%
ROE	-165.30%
ROIC	-96.48%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-6.46%
SMA50	20.23%
SMA200	43.20%
Trades

Shs Outstand	25.78M
Shs Float	18.57M
Short Float	4.79%
Short Ratio	6.42
Short Interest	0.89M
52W High	37.90 -27.86%
52W Low	7.20 279.72%
Volatility	10.96% 13.91%
ATR (14)	3.39
RSI (14)	51.19
Beta	-0.31
Rel Volume	0.00
Avg Volume	138.72K
Volume	0

Perf Week	-6.50%
Perf Month	19.28%
Perf Quarter	1.41%
Perf Half Y	187.79%
Perf YTD	156.23%
Perf Year	164.79%
Perf 3Y	13.92%
Perf 5Y	-81.65%
Perf 10Y	-
Recom	1.22
Target Price	54.88
Prev Close	27.34
Price	27.34
Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)